Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yemaachi Biotechnology has established the world’s most diverse pan-African cancer knowledge base by collecting genomic data from across Africa. Their work has led to the identification of novel biomarkers for early detection of cancers among African populations. They have developed NGS-based diagnostic tools validated through partnerships with academic institutions and industry collaborators. Clinical results are primarily at the pre-clinical or translational stage; no commercialized drugs yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yemaachi Biotechnology.